Document is current
Any future updates will be listed below
-
Authors
Nitahara-Kasahara, Yuko
Kuraoka, Mutsuki
Guillermo, Posadas Herrera
Hayashita-Kinoh, Hiromi
Maruoka, Yasunobu
Nakamura-Takahasi, Aki
Kimura, Koichi
Takeda, Shin’ichi
Okada, Takashi https://orcid.org/0000-0002-2910-3797
-
Funding
Funding for this research was provided by:
Health Sciences Research Grants for Research on Human Genome and Gene Therapy from the Ministry of Health, Labor and Welfare of Japan (21A-3)
Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (22390284, 22-40134)
- License Information
-
More Information
Article History
Received: 13 October 2020
Accepted: 13 December 2020
First Online: 25 January 2021
Ethics approval and consent to participate
: Animal experiments using MSCs were conducted in accordance with the protocol approved by the Institutional Animal Care and Use Committee of Nippon Medical School (27-199) and National Center of Neurology and Psychiatry (NCNP) Animal Ethics Committees (2012011, 2015004, and 19–30-06).
: Not applicable.
: Y. N-K., H. H-K., and T. O. were members of the Division of Cell and Gene Therapy, Nippon Medical School, which is an endowment department, supported with an unrestricted grant from JCR Pharmaceuticals Co., Ltd., and Kaneka Corporation. hDPSCs were provided by JCR Pharmaceuticals Co., Ltd.
